Express Pharma

Ajanta Pharma in NSE’s Nifty Midcap 50 index


The inclusion will take effect from October 19 this year

Ajanta Pharmaceuticals will be included in the NSE’s Nifty Midcap 50 index, replacing Aditya Birla Nuvo from the next month.

The inclusion will take effect from October 19 this year, according to a release by India Index Services and Products Ltd (IISL), a subsidiary of NSE Strategic Investment Corporation.

Aditya Birla Nuvo, the holding company of Aditya Birla Group, will be excluded from the index.

“The Index Maintenance Sub-Committee has decided to make the replacement on account of proposed scheme of arrangement for transfer by way of a demerger of Madura Undertaking of Aditya Birla Nuvo to Pantaloons Fashion & Retail,” the release said.

The Nifty Midcap 50 index consists of stocks with an average free float market capitalisation ranging from Rs 1,000 crores to Rs 5,000 crores at the time of selection.


Comments are closed.